首页> 外文期刊>Journal of pediatric gastroenterology and nutrition >Growth and Tolerance of Preterm Infants Fed a New Extensively Hydrolyzed Liquid Human Milk Fortifier
【24h】

Growth and Tolerance of Preterm Infants Fed a New Extensively Hydrolyzed Liquid Human Milk Fortifier

机译:喂养一种新型的广泛水解的液态人乳强化剂,早产儿的生长和耐受性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objectives: This study was a comparison of growth and tolerance in premature infants fed either standard powdered human milk fortifier ( HMF) or a newly formulated concentrated liquid that contained extensively hydrolyzed protein. Methods: This was an unblinded randomized controlled multicenter noninferiority study on preterm infants receiving human milk ( HM) supplemented with 2 randomly assigned HMFs, either concentrated liquid HMF containing extensively hydrolyzed protein ( LE- HMF) or a powdered intact protein HMF ( PI- HMF) as the control. The study population consisted of preterm infants <= 33 weeks who were enterally fed HM. Infants were studied from the first day of HM fortification until day 29 or hospital discharge, whichever came first. Results: A total of 147 preterm infants were enrolled. Noninferiority was observed in weight gain reported in the intent- to- treat ( ITT) analysis was 18.2 and 17.5 g center dot kg - 1 center dot day - 1 for the LE- HMF and PI- HMF groups, respectively. In an a priori defined subgroup of strict protocol followers ( n = 75), the infants fed LE- HMF achieved greater weight over time than those fed PI- HMF ( P = 0.036). The LE- HMF group achieved greater linear growth over time compared to the PI- HMF ( P = 0.029). The protein intake from fortified HM was significantly higher in the LE- HMF group compared with the PI- HMF group ( 3.9 vs 3.3 g center dot kg - 1 center dot day - 1, P< 0.0001). Both fortifiers were well tolerated with no significant differences in overall morbidity. Conclusions: Both fortifiers showed excellent weight gain ( grams per kilograms per day), tolerance, and low incidence of morbidity outcomes with the infants who were strict protocol followers fed LE- HMF having improved growth during the study. These data point to the safety and suitability of this new concentrated liquid HMF ( LE- HMF) in preterm infants. Growth with this fortifier closely matches the recent recommendations for a weight gain of > 18 g center dot kg-1 center dot day -1.
机译:目的:本研究比较了喂食标准粉状人乳强化剂(HMF)或新配制的含有大量水解蛋白的浓缩液的早产儿的生长和耐受性。方法:这是一项无盲的随机对照多中心非劣效性研究,研究对象是接受补充了2种随机分配的HMF的人乳(HM)的早产儿,这些HMF包含浓缩的HMF液体蛋白(LE-HMF)或粉末状完整蛋白HMF(PI- HMF) )作为控件。研究人群包括接受肠内喂养HM的≤33周的早产儿。从HM设防的第一天到第29天或医院出院(以先到者为准)对婴儿进行研究。结果:共纳入147名早产儿。 LE-HMF和PI-HMF组在意向治疗(ITT)分析中报告的体重增加非劣性分别为18.2和17.5 g中心点kg-1中心点天-1。在一个严格的规程追踪者的先验定义亚组(n = 75)中,喂食LE-HMF的婴儿随时间的体重比喂食PI-HMF的婴儿更大(P = 0.036)。与PI-HMF相比,LE-HMF组随着时间的推移实现了更大的线性增长(P = 0.029)。与PI-HMF组相比,LE-HMF组从强化HM中摄入的蛋白质明显更高(3.9 vs 3.3 g中心点kg-1个中心点天-1,P <0.0001)。两种强化剂的耐受性均良好,总体发病率无显着差异。结论:这两种强化剂均表现出出色的体重增加(克每千克每天),耐受性和发病率较低的婴儿,这些婴儿是严格的方案随访者,接受LE-HMF喂养,在研究过程中生长得到改善。这些数据表明这种新型浓缩液态HMF(LE-HMF)在早产儿中的安全性和适用性。使用这种强化剂的生长与最近建议的体重增加> 18 g中心点kg-1中心点第-1天非常接近。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号